Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:( Population pharmacokinetics). Showing records 1 – 30 of 62 total matches.

[1] [2] [3]

Search Limiters

Last 2 Years | English Only

Degrees

Languages

Country

▼ Search Limiters


Université Catholique de Louvain

1. Guy-Viterbo, Vanessa. Toward individualization regimen of tacrolimus in pediatric liver transplantation.

Degree: 2019, Université Catholique de Louvain

Tacrolimus (Tac) is the cornerstone of immunosuppression in pediatric liver transplantation (PLT). However, its use is complicated by side effects and lack of efficacy partly… (more)

Subjects/Keywords: Population pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Guy-Viterbo, V. (2019). Toward individualization regimen of tacrolimus in pediatric liver transplantation. (Thesis). Université Catholique de Louvain. Retrieved from http://hdl.handle.net/2078.1/220246

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Guy-Viterbo, Vanessa. “Toward individualization regimen of tacrolimus in pediatric liver transplantation.” 2019. Thesis, Université Catholique de Louvain. Accessed August 07, 2020. http://hdl.handle.net/2078.1/220246.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Guy-Viterbo, Vanessa. “Toward individualization regimen of tacrolimus in pediatric liver transplantation.” 2019. Web. 07 Aug 2020.

Vancouver:

Guy-Viterbo V. Toward individualization regimen of tacrolimus in pediatric liver transplantation. [Internet] [Thesis]. Université Catholique de Louvain; 2019. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2078.1/220246.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Guy-Viterbo V. Toward individualization regimen of tacrolimus in pediatric liver transplantation. [Thesis]. Université Catholique de Louvain; 2019. Available from: http://hdl.handle.net/2078.1/220246

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Manchester

2. Tsamandouras, Nikolaos. Development and applications of physiologically-based pharmacokinetic models for population data analyses.

Degree: 2015, University of Manchester

 Physiologically-based pharmacokinetic (PBPK) modelling is traditionally employed to predict drug concentration-time profiles in plasma and tissues using information from physiology / biology, in vitro experiments… (more)

Subjects/Keywords: PBPK modelling; population pharmacokinetics; simvastatin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tsamandouras, N. (2015). Development and applications of physiologically-based pharmacokinetic models for population data analyses. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:260385

Chicago Manual of Style (16th Edition):

Tsamandouras, Nikolaos. “Development and applications of physiologically-based pharmacokinetic models for population data analyses.” 2015. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:260385.

MLA Handbook (7th Edition):

Tsamandouras, Nikolaos. “Development and applications of physiologically-based pharmacokinetic models for population data analyses.” 2015. Web. 07 Aug 2020.

Vancouver:

Tsamandouras N. Development and applications of physiologically-based pharmacokinetic models for population data analyses. [Internet] [Doctoral dissertation]. University of Manchester; 2015. [cited 2020 Aug 07]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:260385.

Council of Science Editors:

Tsamandouras N. Development and applications of physiologically-based pharmacokinetic models for population data analyses. [Doctoral Dissertation]. University of Manchester; 2015. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:260385


Iowa State University

3. Kittrell, Heather. An investigation of the pharmacokinetics of flunixin meglumine in swine using noncompartmental analysis and nonlinear mixed-effects modeling: An emphasis on pre-wean piglets.

Degree: 2020, Iowa State University

 With the transdermal (TD) application of flunixin meglumine (FM) now approved for pain control in cattle, Animal Medicinal Drug Use Clarification Act (AMDUCA) algorithms suggest… (more)

Subjects/Keywords: flunixin; pharmacokinetics; population; swine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kittrell, H. (2020). An investigation of the pharmacokinetics of flunixin meglumine in swine using noncompartmental analysis and nonlinear mixed-effects modeling: An emphasis on pre-wean piglets. (Thesis). Iowa State University. Retrieved from https://lib.dr.iastate.edu/etd/18037

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kittrell, Heather. “An investigation of the pharmacokinetics of flunixin meglumine in swine using noncompartmental analysis and nonlinear mixed-effects modeling: An emphasis on pre-wean piglets.” 2020. Thesis, Iowa State University. Accessed August 07, 2020. https://lib.dr.iastate.edu/etd/18037.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kittrell, Heather. “An investigation of the pharmacokinetics of flunixin meglumine in swine using noncompartmental analysis and nonlinear mixed-effects modeling: An emphasis on pre-wean piglets.” 2020. Web. 07 Aug 2020.

Vancouver:

Kittrell H. An investigation of the pharmacokinetics of flunixin meglumine in swine using noncompartmental analysis and nonlinear mixed-effects modeling: An emphasis on pre-wean piglets. [Internet] [Thesis]. Iowa State University; 2020. [cited 2020 Aug 07]. Available from: https://lib.dr.iastate.edu/etd/18037.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kittrell H. An investigation of the pharmacokinetics of flunixin meglumine in swine using noncompartmental analysis and nonlinear mixed-effects modeling: An emphasis on pre-wean piglets. [Thesis]. Iowa State University; 2020. Available from: https://lib.dr.iastate.edu/etd/18037

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

4. Tsamandouras, Nikolaos. Development and applications of physiologically-based pharmacokinetic models for population data analyses.

Degree: PhD, 2015, University of Manchester

 Physiologically-based pharmacokinetic (PBPK) modelling is traditionally employed to predict drug concentration-time profiles in plasma and tissues using information from physiology/biology, in vitro experiments and in… (more)

Subjects/Keywords: 615.7; PBPK modelling; population pharmacokinetics; simvastatin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tsamandouras, N. (2015). Development and applications of physiologically-based pharmacokinetic models for population data analyses. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/development-and-applications-of-physiologicallybased-pharmacokinetic-models-for-population-data-analyses(5793d86f-75e4-4ed9-89ec-b93e9bc6b2e6).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.686748

Chicago Manual of Style (16th Edition):

Tsamandouras, Nikolaos. “Development and applications of physiologically-based pharmacokinetic models for population data analyses.” 2015. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. https://www.research.manchester.ac.uk/portal/en/theses/development-and-applications-of-physiologicallybased-pharmacokinetic-models-for-population-data-analyses(5793d86f-75e4-4ed9-89ec-b93e9bc6b2e6).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.686748.

MLA Handbook (7th Edition):

Tsamandouras, Nikolaos. “Development and applications of physiologically-based pharmacokinetic models for population data analyses.” 2015. Web. 07 Aug 2020.

Vancouver:

Tsamandouras N. Development and applications of physiologically-based pharmacokinetic models for population data analyses. [Internet] [Doctoral dissertation]. University of Manchester; 2015. [cited 2020 Aug 07]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/development-and-applications-of-physiologicallybased-pharmacokinetic-models-for-population-data-analyses(5793d86f-75e4-4ed9-89ec-b93e9bc6b2e6).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.686748.

Council of Science Editors:

Tsamandouras N. Development and applications of physiologically-based pharmacokinetic models for population data analyses. [Doctoral Dissertation]. University of Manchester; 2015. Available from: https://www.research.manchester.ac.uk/portal/en/theses/development-and-applications-of-physiologicallybased-pharmacokinetic-models-for-population-data-analyses(5793d86f-75e4-4ed9-89ec-b93e9bc6b2e6).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.686748


University of New South Wales

5. Kumar, Shaun. Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes.

Degree: Medical Sciences, 2016, University of New South Wales

 Dose selection is a critical part of individualising pharmacotherapy in order to ensure optimal safety and effectiveness. Population pharmacokinetic and/or pharmacodynamic modelling paired with Bayesian… (more)

Subjects/Keywords: Population pharmacodynamics; Pharmacometrics; Population pharmacokinetics; Ribavirin; Imatinib; Metformin; Dose individualisation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kumar, S. (2016). Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/55575 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:38076/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Kumar, Shaun. “Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes.” 2016. Doctoral Dissertation, University of New South Wales. Accessed August 07, 2020. http://handle.unsw.edu.au/1959.4/55575 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:38076/SOURCE02?view=true.

MLA Handbook (7th Edition):

Kumar, Shaun. “Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes.” 2016. Web. 07 Aug 2020.

Vancouver:

Kumar S. Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes. [Internet] [Doctoral dissertation]. University of New South Wales; 2016. [cited 2020 Aug 07]. Available from: http://handle.unsw.edu.au/1959.4/55575 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:38076/SOURCE02?view=true.

Council of Science Editors:

Kumar S. Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes. [Doctoral Dissertation]. University of New South Wales; 2016. Available from: http://handle.unsw.edu.au/1959.4/55575 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:38076/SOURCE02?view=true


University of Minnesota

6. Ahmed, Mariam. Application of Pharmacometrics to Rare Diseases.

Degree: PhD, Experimental & Clinical Pharmacology, 2016, University of Minnesota

 Rare diseases affect an estimated 600–700 million people across the globe and are often chronic, progressive, degenerative, and life threatening.  In United States, there are… (more)

Subjects/Keywords: Cortisol; Lorenzo's oil; NONMEM; Pediatrics; Population pharmacodynamics; Population Pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ahmed, M. (2016). Application of Pharmacometrics to Rare Diseases. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/183406

Chicago Manual of Style (16th Edition):

Ahmed, Mariam. “Application of Pharmacometrics to Rare Diseases.” 2016. Doctoral Dissertation, University of Minnesota. Accessed August 07, 2020. http://hdl.handle.net/11299/183406.

MLA Handbook (7th Edition):

Ahmed, Mariam. “Application of Pharmacometrics to Rare Diseases.” 2016. Web. 07 Aug 2020.

Vancouver:

Ahmed M. Application of Pharmacometrics to Rare Diseases. [Internet] [Doctoral dissertation]. University of Minnesota; 2016. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11299/183406.

Council of Science Editors:

Ahmed M. Application of Pharmacometrics to Rare Diseases. [Doctoral Dissertation]. University of Minnesota; 2016. Available from: http://hdl.handle.net/11299/183406

7. Bardin, Christophe. Evaluation de différents descripteurs de poids chez le sujet obèse à l’aide d’un modèle de pharmacocinétique de population - application à la metformine, la morphine et l’imatinib : Evaluation of different size-descriptors in obese subjects using population pharmacokinetic model : application to metformin, morphine, imatinib.

Degree: Docteur es, Pharmacologie, 2012, Université Paris Descartes – Paris V

Les modifications physiopathologiques induites par l’obésité sont susceptibles de modifier la pharmacocinétique d’un grand nombre de médicaments. Toutes les étapes peuvent-être touchées : modification des… (more)

Subjects/Keywords: Pharmacocinétique de population; Obésité; Imatinib; Morphine; Metformine; Population pharmacokinetics; Obesity; Imatinib; Morphine; Metformin; 616.398 061

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bardin, C. (2012). Evaluation de différents descripteurs de poids chez le sujet obèse à l’aide d’un modèle de pharmacocinétique de population - application à la metformine, la morphine et l’imatinib : Evaluation of different size-descriptors in obese subjects using population pharmacokinetic model : application to metformin, morphine, imatinib. (Doctoral Dissertation). Université Paris Descartes – Paris V. Retrieved from http://www.theses.fr/2012PA05P649

Chicago Manual of Style (16th Edition):

Bardin, Christophe. “Evaluation de différents descripteurs de poids chez le sujet obèse à l’aide d’un modèle de pharmacocinétique de population - application à la metformine, la morphine et l’imatinib : Evaluation of different size-descriptors in obese subjects using population pharmacokinetic model : application to metformin, morphine, imatinib.” 2012. Doctoral Dissertation, Université Paris Descartes – Paris V. Accessed August 07, 2020. http://www.theses.fr/2012PA05P649.

MLA Handbook (7th Edition):

Bardin, Christophe. “Evaluation de différents descripteurs de poids chez le sujet obèse à l’aide d’un modèle de pharmacocinétique de population - application à la metformine, la morphine et l’imatinib : Evaluation of different size-descriptors in obese subjects using population pharmacokinetic model : application to metformin, morphine, imatinib.” 2012. Web. 07 Aug 2020.

Vancouver:

Bardin C. Evaluation de différents descripteurs de poids chez le sujet obèse à l’aide d’un modèle de pharmacocinétique de population - application à la metformine, la morphine et l’imatinib : Evaluation of different size-descriptors in obese subjects using population pharmacokinetic model : application to metformin, morphine, imatinib. [Internet] [Doctoral dissertation]. Université Paris Descartes – Paris V; 2012. [cited 2020 Aug 07]. Available from: http://www.theses.fr/2012PA05P649.

Council of Science Editors:

Bardin C. Evaluation de différents descripteurs de poids chez le sujet obèse à l’aide d’un modèle de pharmacocinétique de population - application à la metformine, la morphine et l’imatinib : Evaluation of different size-descriptors in obese subjects using population pharmacokinetic model : application to metformin, morphine, imatinib. [Doctoral Dissertation]. Université Paris Descartes – Paris V; 2012. Available from: http://www.theses.fr/2012PA05P649

8. Martinez, Jean-Marie. Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data.

Degree: Docteur es, Sciences du médicament, 2010, Université Montpellier I

Par l'utilisation de techniques statistiques poussées, l'approche de population rend l'estimation des propriétés pharmacocinétiques (étude des phénomènes d'absorption, distribution, métabolisme et élimination du médicament dans… (more)

Subjects/Keywords: Pharmacocinétique; Population; Développement clinique; Phase III; Pharmacokinetics; Population; Clinical Drug Development; Phase III

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Martinez, J. (2010). Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data. (Doctoral Dissertation). Université Montpellier I. Retrieved from http://www.theses.fr/2010MON13511

Chicago Manual of Style (16th Edition):

Martinez, Jean-Marie. “Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data.” 2010. Doctoral Dissertation, Université Montpellier I. Accessed August 07, 2020. http://www.theses.fr/2010MON13511.

MLA Handbook (7th Edition):

Martinez, Jean-Marie. “Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data.” 2010. Web. 07 Aug 2020.

Vancouver:

Martinez J. Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data. [Internet] [Doctoral dissertation]. Université Montpellier I; 2010. [cited 2020 Aug 07]. Available from: http://www.theses.fr/2010MON13511.

Council of Science Editors:

Martinez J. Contribution de l'approche de pharmacocinétique de population au développement clinique des médicaments : application aux données de phase III : Contribution of pharmacokinetic population approach to clinical drug development : application to phase III data. [Doctoral Dissertation]. Université Montpellier I; 2010. Available from: http://www.theses.fr/2010MON13511

9. Riff, Camille. Pharmacocinétique de la ropivacaïne et de la lidocaïne au cours de la chirurgie carcinologique du sein et évaluation de la toxicité aux anesthésiques locaux en anesthésie locorégionale : Pharmacokinetic of ropivacaine and lidocaine in breast cancer surgery and evaluation of local anaesthetics in locoregional anesthesia.

Degree: Docteur es, Neurosciences, 2018, Aix Marseille Université

Ces dernières décennies, de nouvelles techniques d’anesthésie-analgésie locorégionales ont permis d’améliorer la prise en charge post-opératoire. Cependant, les anesthésiques locaux (AL) exposent les patients à… (more)

Subjects/Keywords: Anesthésiques locaux; Pharmacocinétique; Modèle non linéaire; Approche de population; Local anaesthetic; Pharmacokinetics; Population modeling approaches

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Riff, C. (2018). Pharmacocinétique de la ropivacaïne et de la lidocaïne au cours de la chirurgie carcinologique du sein et évaluation de la toxicité aux anesthésiques locaux en anesthésie locorégionale : Pharmacokinetic of ropivacaine and lidocaine in breast cancer surgery and evaluation of local anaesthetics in locoregional anesthesia. (Doctoral Dissertation). Aix Marseille Université. Retrieved from http://www.theses.fr/2018AIXM0395

Chicago Manual of Style (16th Edition):

Riff, Camille. “Pharmacocinétique de la ropivacaïne et de la lidocaïne au cours de la chirurgie carcinologique du sein et évaluation de la toxicité aux anesthésiques locaux en anesthésie locorégionale : Pharmacokinetic of ropivacaine and lidocaine in breast cancer surgery and evaluation of local anaesthetics in locoregional anesthesia.” 2018. Doctoral Dissertation, Aix Marseille Université. Accessed August 07, 2020. http://www.theses.fr/2018AIXM0395.

MLA Handbook (7th Edition):

Riff, Camille. “Pharmacocinétique de la ropivacaïne et de la lidocaïne au cours de la chirurgie carcinologique du sein et évaluation de la toxicité aux anesthésiques locaux en anesthésie locorégionale : Pharmacokinetic of ropivacaine and lidocaine in breast cancer surgery and evaluation of local anaesthetics in locoregional anesthesia.” 2018. Web. 07 Aug 2020.

Vancouver:

Riff C. Pharmacocinétique de la ropivacaïne et de la lidocaïne au cours de la chirurgie carcinologique du sein et évaluation de la toxicité aux anesthésiques locaux en anesthésie locorégionale : Pharmacokinetic of ropivacaine and lidocaine in breast cancer surgery and evaluation of local anaesthetics in locoregional anesthesia. [Internet] [Doctoral dissertation]. Aix Marseille Université 2018. [cited 2020 Aug 07]. Available from: http://www.theses.fr/2018AIXM0395.

Council of Science Editors:

Riff C. Pharmacocinétique de la ropivacaïne et de la lidocaïne au cours de la chirurgie carcinologique du sein et évaluation de la toxicité aux anesthésiques locaux en anesthésie locorégionale : Pharmacokinetic of ropivacaine and lidocaine in breast cancer surgery and evaluation of local anaesthetics in locoregional anesthesia. [Doctoral Dissertation]. Aix Marseille Université 2018. Available from: http://www.theses.fr/2018AIXM0395


Erasmus University Rotterdam

10. Vossen, Annette. Paediatric formulations : pharmaceutical development and clinical evaluation.

Degree: 2018, Erasmus University Rotterdam

 textabstractDrug development for children has long been a neglected area compared to adult drug development. There are many ‘older’ medicines that have an important place… (more)

Subjects/Keywords: Paediatric formulations; compounding; population pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vossen, A. (2018). Paediatric formulations : pharmaceutical development and clinical evaluation. (Doctoral Dissertation). Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/112858

Chicago Manual of Style (16th Edition):

Vossen, Annette. “Paediatric formulations : pharmaceutical development and clinical evaluation.” 2018. Doctoral Dissertation, Erasmus University Rotterdam. Accessed August 07, 2020. http://hdl.handle.net/1765/112858.

MLA Handbook (7th Edition):

Vossen, Annette. “Paediatric formulations : pharmaceutical development and clinical evaluation.” 2018. Web. 07 Aug 2020.

Vancouver:

Vossen A. Paediatric formulations : pharmaceutical development and clinical evaluation. [Internet] [Doctoral dissertation]. Erasmus University Rotterdam; 2018. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/1765/112858.

Council of Science Editors:

Vossen A. Paediatric formulations : pharmaceutical development and clinical evaluation. [Doctoral Dissertation]. Erasmus University Rotterdam; 2018. Available from: http://hdl.handle.net/1765/112858

11. Chirehwa, Maxwell Tawanda. Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment.

Degree: Image, Division of Clinical Pharmacology, 2018, University of Cape Town

 The pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in TB/HIV coinfected patients recruited in two phase III clinical trials (61 patients in TB-HAART and 222… (more)

Subjects/Keywords: population; Nonlinear mixed-effects modelling; pharmacokinetics; tuberculos pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chirehwa, M. T. (2018). Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment. (Thesis). University of Cape Town. Retrieved from http://hdl.handle.net/11427/28429

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chirehwa, Maxwell Tawanda. “Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment.” 2018. Thesis, University of Cape Town. Accessed August 07, 2020. http://hdl.handle.net/11427/28429.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chirehwa, Maxwell Tawanda. “Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment.” 2018. Web. 07 Aug 2020.

Vancouver:

Chirehwa MT. Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment. [Internet] [Thesis]. University of Cape Town; 2018. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11427/28429.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chirehwa MT. Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment. [Thesis]. University of Cape Town; 2018. Available from: http://hdl.handle.net/11427/28429

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cincinnati

12. Bhongsatiern, Jiraganya (JJ). Population Pharmacokinetics and Dosing Recommendations of Vancomycin in Neonates Using Modeling and Simulation Approach.

Degree: PhD, Pharmacy: Pharmaceutical Sciences/Biopharmaceutics, 2015, University of Cincinnati

 Sources of variability in drug exposure play an important role in evidence-based drug dosing strategies. Body size representing growth and age representing developmental changes are… (more)

Subjects/Keywords: Pharmaceuticals; population pharmacokinetics; infectious diseases; special populations; neonates; vancomycin; dosing strategy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bhongsatiern, J. (. (2015). Population Pharmacokinetics and Dosing Recommendations of Vancomycin in Neonates Using Modeling and Simulation Approach. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1447689427

Chicago Manual of Style (16th Edition):

Bhongsatiern, Jiraganya (JJ). “Population Pharmacokinetics and Dosing Recommendations of Vancomycin in Neonates Using Modeling and Simulation Approach.” 2015. Doctoral Dissertation, University of Cincinnati. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1447689427.

MLA Handbook (7th Edition):

Bhongsatiern, Jiraganya (JJ). “Population Pharmacokinetics and Dosing Recommendations of Vancomycin in Neonates Using Modeling and Simulation Approach.” 2015. Web. 07 Aug 2020.

Vancouver:

Bhongsatiern J(. Population Pharmacokinetics and Dosing Recommendations of Vancomycin in Neonates Using Modeling and Simulation Approach. [Internet] [Doctoral dissertation]. University of Cincinnati; 2015. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1447689427.

Council of Science Editors:

Bhongsatiern J(. Population Pharmacokinetics and Dosing Recommendations of Vancomycin in Neonates Using Modeling and Simulation Approach. [Doctoral Dissertation]. University of Cincinnati; 2015. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1447689427


Univerzitet u Beogradu

13. Jovanović, Marija N., 1983-. Identifikacija i kvantifikacija faktora varijabilnosti topiramata kod odraskih pacijenata sa epilepsijom.

Degree: Farmaceutski fakultet, 2016, Univerzitet u Beogradu

Farmacija - Farmakokinetika i klinička farmacija / Pharmacy - Pharmacokinetics and Clinical Pharmacy

Cilj doktorske disertacije je bio da se istraže, otkriju i kvantitativno izraze… (more)

Subjects/Keywords: antiepileptic drugs; pharmacokinetics; population modeling; pharmacometrics; NONMEM; interaction; safety profile; bicarbonates

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jovanović, Marija N., 1. (2016). Identifikacija i kvantifikacija faktora varijabilnosti topiramata kod odraskih pacijenata sa epilepsijom. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:12612/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Jovanović, Marija N., 1983-. “Identifikacija i kvantifikacija faktora varijabilnosti topiramata kod odraskih pacijenata sa epilepsijom.” 2016. Thesis, Univerzitet u Beogradu. Accessed August 07, 2020. https://fedorabg.bg.ac.rs/fedora/get/o:12612/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Jovanović, Marija N., 1983-. “Identifikacija i kvantifikacija faktora varijabilnosti topiramata kod odraskih pacijenata sa epilepsijom.” 2016. Web. 07 Aug 2020.

Vancouver:

Jovanović, Marija N. 1. Identifikacija i kvantifikacija faktora varijabilnosti topiramata kod odraskih pacijenata sa epilepsijom. [Internet] [Thesis]. Univerzitet u Beogradu; 2016. [cited 2020 Aug 07]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:12612/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Jovanović, Marija N. 1. Identifikacija i kvantifikacija faktora varijabilnosti topiramata kod odraskih pacijenata sa epilepsijom. [Thesis]. Univerzitet u Beogradu; 2016. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:12612/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of the Western Cape

14. Mulubwa, Mwila. Population pharmacokinetics of terizidone and cycloserine in patients with drugresistant tuberculosis .

Degree: 2019, University of the Western Cape

 Introduction: Drug-resistant tuberculosis remains a major world health problem and one of the leading cause of death worldwide. Despite adequate adherence to antituberculosis drugs by… (more)

Subjects/Keywords: Terizidone; Drug-resistant tuberculosis; Metabolism; Cycloserine; Population pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mulubwa, M. (2019). Population pharmacokinetics of terizidone and cycloserine in patients with drugresistant tuberculosis . (Thesis). University of the Western Cape. Retrieved from http://hdl.handle.net/11394/7083

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mulubwa, Mwila. “Population pharmacokinetics of terizidone and cycloserine in patients with drugresistant tuberculosis .” 2019. Thesis, University of the Western Cape. Accessed August 07, 2020. http://hdl.handle.net/11394/7083.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mulubwa, Mwila. “Population pharmacokinetics of terizidone and cycloserine in patients with drugresistant tuberculosis .” 2019. Web. 07 Aug 2020.

Vancouver:

Mulubwa M. Population pharmacokinetics of terizidone and cycloserine in patients with drugresistant tuberculosis . [Internet] [Thesis]. University of the Western Cape; 2019. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11394/7083.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mulubwa M. Population pharmacokinetics of terizidone and cycloserine in patients with drugresistant tuberculosis . [Thesis]. University of the Western Cape; 2019. Available from: http://hdl.handle.net/11394/7083

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Minnesota

15. Passey, Chaitali. Application of pharmacometrics for covariate selection and dose optimization of tacrolimus in adult kidney transplant recipients.

Degree: PhD, Experimental & Clinical Pharmacology, 2012, University of Minnesota

 In spite of rigorous dose adjustments by way of therapeutic drug monitoring, a large proportion of kidney transplant recipients are unable to achieve the target… (more)

Subjects/Keywords: Covariate selection; Dosing; NONMEM; Pharmacogenomics; Population pharmacokinetics; Tacrolimus; Experimental & clinical pharmacology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Passey, C. (2012). Application of pharmacometrics for covariate selection and dose optimization of tacrolimus in adult kidney transplant recipients. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/171675

Chicago Manual of Style (16th Edition):

Passey, Chaitali. “Application of pharmacometrics for covariate selection and dose optimization of tacrolimus in adult kidney transplant recipients.” 2012. Doctoral Dissertation, University of Minnesota. Accessed August 07, 2020. http://hdl.handle.net/11299/171675.

MLA Handbook (7th Edition):

Passey, Chaitali. “Application of pharmacometrics for covariate selection and dose optimization of tacrolimus in adult kidney transplant recipients.” 2012. Web. 07 Aug 2020.

Vancouver:

Passey C. Application of pharmacometrics for covariate selection and dose optimization of tacrolimus in adult kidney transplant recipients. [Internet] [Doctoral dissertation]. University of Minnesota; 2012. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11299/171675.

Council of Science Editors:

Passey C. Application of pharmacometrics for covariate selection and dose optimization of tacrolimus in adult kidney transplant recipients. [Doctoral Dissertation]. University of Minnesota; 2012. Available from: http://hdl.handle.net/11299/171675


University of Iowa

16. Morris, Denise Nichole. Population pharmacokinetics of telapristone and its active metabolite CDB-4453.

Degree: PhD, Pharmacy, 2011, University of Iowa

  In this thesis, the population pharmacokinetics of telapristone and its active metabolite, CDB-4453 was evaluated using nonlinear mixed effects modeling (NONMEM®). A two-compartment (parent)… (more)

Subjects/Keywords: Mixture Modeling; NONMEM; Parent-metabolite; Population Pharmacokinetics; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Morris, D. N. (2011). Population pharmacokinetics of telapristone and its active metabolite CDB-4453. (Doctoral Dissertation). University of Iowa. Retrieved from https://ir.uiowa.edu/etd/1034

Chicago Manual of Style (16th Edition):

Morris, Denise Nichole. “Population pharmacokinetics of telapristone and its active metabolite CDB-4453.” 2011. Doctoral Dissertation, University of Iowa. Accessed August 07, 2020. https://ir.uiowa.edu/etd/1034.

MLA Handbook (7th Edition):

Morris, Denise Nichole. “Population pharmacokinetics of telapristone and its active metabolite CDB-4453.” 2011. Web. 07 Aug 2020.

Vancouver:

Morris DN. Population pharmacokinetics of telapristone and its active metabolite CDB-4453. [Internet] [Doctoral dissertation]. University of Iowa; 2011. [cited 2020 Aug 07]. Available from: https://ir.uiowa.edu/etd/1034.

Council of Science Editors:

Morris DN. Population pharmacokinetics of telapristone and its active metabolite CDB-4453. [Doctoral Dissertation]. University of Iowa; 2011. Available from: https://ir.uiowa.edu/etd/1034


University of Southern California

17. Zhu, Rui. Isoniazid population pharmacokinetics in HIV perinatally exposed infants.

Degree: PhD, Biomedical Engineering, 2011, University of Southern California

 Pediatric tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection results in considerable childhood morbidity and mortality. Results of a randomized, double-blind, controlled trial of isoniazid… (more)

Subjects/Keywords: population pharmacokinetics; pharmacogenetics; NAT2 enzyme maturation; infants; isoniazid

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhu, R. (2011). Isoniazid population pharmacokinetics in HIV perinatally exposed infants. (Doctoral Dissertation). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/432353/rec/3671

Chicago Manual of Style (16th Edition):

Zhu, Rui. “Isoniazid population pharmacokinetics in HIV perinatally exposed infants.” 2011. Doctoral Dissertation, University of Southern California. Accessed August 07, 2020. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/432353/rec/3671.

MLA Handbook (7th Edition):

Zhu, Rui. “Isoniazid population pharmacokinetics in HIV perinatally exposed infants.” 2011. Web. 07 Aug 2020.

Vancouver:

Zhu R. Isoniazid population pharmacokinetics in HIV perinatally exposed infants. [Internet] [Doctoral dissertation]. University of Southern California; 2011. [cited 2020 Aug 07]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/432353/rec/3671.

Council of Science Editors:

Zhu R. Isoniazid population pharmacokinetics in HIV perinatally exposed infants. [Doctoral Dissertation]. University of Southern California; 2011. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/432353/rec/3671

18. Mason, Sharon. Comparative Pharmacokinetic Approaches to Estimating the Pharmacokinetics of Water Medications in Swine.

Degree: PhD, Comparative Biomedical Sciences, 2010, North Carolina State University

 ABSTRACT MASON, SHARON ELIZABETH. Comparative Pharmacokinetic Approaches to Estimating the Pharmacokinetics of Water Medications in Swine. (under the direction of Ronald E. Baynes). Although water… (more)

Subjects/Keywords: pharmacokinetics; swine; PBPK; population pharmacokinetics; water medication

Population Pharmacokinetics …. … Modeling Water Medications in Herds… …increased understanding and implementation of population 1 pharmacokinetics, but do not require… …the Pharmacokinetics of Water Medications in Swine. (Under the direction of Ronald E… …the pharmacokinetics of these drugs have not been clearly discerned using compartmental… …pharmacokinetics techniques. No repeated dosing pharmacokinetic studies have been published on water… 

Page 1 Page 2 Page 3 Page 4 Page 5

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mason, S. (2010). Comparative Pharmacokinetic Approaches to Estimating the Pharmacokinetics of Water Medications in Swine. (Doctoral Dissertation). North Carolina State University. Retrieved from http://www.lib.ncsu.edu/resolver/1840.16/6203

Chicago Manual of Style (16th Edition):

Mason, Sharon. “Comparative Pharmacokinetic Approaches to Estimating the Pharmacokinetics of Water Medications in Swine.” 2010. Doctoral Dissertation, North Carolina State University. Accessed August 07, 2020. http://www.lib.ncsu.edu/resolver/1840.16/6203.

MLA Handbook (7th Edition):

Mason, Sharon. “Comparative Pharmacokinetic Approaches to Estimating the Pharmacokinetics of Water Medications in Swine.” 2010. Web. 07 Aug 2020.

Vancouver:

Mason S. Comparative Pharmacokinetic Approaches to Estimating the Pharmacokinetics of Water Medications in Swine. [Internet] [Doctoral dissertation]. North Carolina State University; 2010. [cited 2020 Aug 07]. Available from: http://www.lib.ncsu.edu/resolver/1840.16/6203.

Council of Science Editors:

Mason S. Comparative Pharmacokinetic Approaches to Estimating the Pharmacokinetics of Water Medications in Swine. [Doctoral Dissertation]. North Carolina State University; 2010. Available from: http://www.lib.ncsu.edu/resolver/1840.16/6203


University of Waterloo

19. McEneny-King, Alanna. Pharmacokinetic modelling of clinically relevant situations in the treatment of hemophilia A and B.

Degree: 2020, University of Waterloo

 Hemophilia is a congenital bleeding disorder caused by deficiency of clotting factor VIII (FVIII; hemophilia A) or IX (FIX; hemophilia B). Severe hemophilia patients have… (more)

Subjects/Keywords: hemophilia; hemophilia A; hemophilia B; factor VIII; factor IX; population pharmacokinetics; dose tailoring; dose individualization; nonlinear mixed effects modelling; Pharmacokinetics; Hemophilia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McEneny-King, A. (2020). Pharmacokinetic modelling of clinically relevant situations in the treatment of hemophilia A and B. (Thesis). University of Waterloo. Retrieved from http://hdl.handle.net/10012/15738

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

McEneny-King, Alanna. “Pharmacokinetic modelling of clinically relevant situations in the treatment of hemophilia A and B.” 2020. Thesis, University of Waterloo. Accessed August 07, 2020. http://hdl.handle.net/10012/15738.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

McEneny-King, Alanna. “Pharmacokinetic modelling of clinically relevant situations in the treatment of hemophilia A and B.” 2020. Web. 07 Aug 2020.

Vancouver:

McEneny-King A. Pharmacokinetic modelling of clinically relevant situations in the treatment of hemophilia A and B. [Internet] [Thesis]. University of Waterloo; 2020. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10012/15738.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

McEneny-King A. Pharmacokinetic modelling of clinically relevant situations in the treatment of hemophilia A and B. [Thesis]. University of Waterloo; 2020. Available from: http://hdl.handle.net/10012/15738

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Helsinki

20. Bäckström, Mia. Clinical research of dexmedetomidine in healthy volunteers.

Degree: Farmaceutiska fakulteten, 2017, University of Helsinki

Background: Dexmedetomdine is a α2-adrenergic receptor agonist, which by binding to the α2-adrenergic receptor in the sympathetic nervous system exhibits sedative effect. Additionally, it has… (more)

Subjects/Keywords: dexmedetomidine; pharmacokinetics; population modeling; nonlinear mixed effects model; α2-agonist; dexmedetomidine; Biofarmaci; Biopharmacy; Biofarmasia; dexmedetomidine; pharmacokinetics; population modeling; nonlinear mixed effects model; α2-agonist; dexmedetomidine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bäckström, M. (2017). Clinical research of dexmedetomidine in healthy volunteers. (Masters Thesis). University of Helsinki. Retrieved from http://hdl.handle.net/10138/199531

Chicago Manual of Style (16th Edition):

Bäckström, Mia. “Clinical research of dexmedetomidine in healthy volunteers.” 2017. Masters Thesis, University of Helsinki. Accessed August 07, 2020. http://hdl.handle.net/10138/199531.

MLA Handbook (7th Edition):

Bäckström, Mia. “Clinical research of dexmedetomidine in healthy volunteers.” 2017. Web. 07 Aug 2020.

Vancouver:

Bäckström M. Clinical research of dexmedetomidine in healthy volunteers. [Internet] [Masters thesis]. University of Helsinki; 2017. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10138/199531.

Council of Science Editors:

Bäckström M. Clinical research of dexmedetomidine in healthy volunteers. [Masters Thesis]. University of Helsinki; 2017. Available from: http://hdl.handle.net/10138/199531


University of Kentucky

21. Tsakalozou, Eleftheria. PRECLINICAL AND CLINICAL DEVELOPMENT OF THE LIPOPHILIC CAMPTOTHECIN ANALOGUE AR-67.

Degree: 2013, University of Kentucky

 AR-67 is a lipophilic third generation camptothecin analogue, currently under early stage clinical trials. It acts by targeting Topoisomerase 1 (Top1), a nuclear enzyme essential… (more)

Subjects/Keywords: AR-67; Camptothecin; Transporter; Dosing Schedule; Population Pharmacokinetics; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tsakalozou, E. (2013). PRECLINICAL AND CLINICAL DEVELOPMENT OF THE LIPOPHILIC CAMPTOTHECIN ANALOGUE AR-67. (Doctoral Dissertation). University of Kentucky. Retrieved from https://uknowledge.uky.edu/pharmacy_etds/18

Chicago Manual of Style (16th Edition):

Tsakalozou, Eleftheria. “PRECLINICAL AND CLINICAL DEVELOPMENT OF THE LIPOPHILIC CAMPTOTHECIN ANALOGUE AR-67.” 2013. Doctoral Dissertation, University of Kentucky. Accessed August 07, 2020. https://uknowledge.uky.edu/pharmacy_etds/18.

MLA Handbook (7th Edition):

Tsakalozou, Eleftheria. “PRECLINICAL AND CLINICAL DEVELOPMENT OF THE LIPOPHILIC CAMPTOTHECIN ANALOGUE AR-67.” 2013. Web. 07 Aug 2020.

Vancouver:

Tsakalozou E. PRECLINICAL AND CLINICAL DEVELOPMENT OF THE LIPOPHILIC CAMPTOTHECIN ANALOGUE AR-67. [Internet] [Doctoral dissertation]. University of Kentucky; 2013. [cited 2020 Aug 07]. Available from: https://uknowledge.uky.edu/pharmacy_etds/18.

Council of Science Editors:

Tsakalozou E. PRECLINICAL AND CLINICAL DEVELOPMENT OF THE LIPOPHILIC CAMPTOTHECIN ANALOGUE AR-67. [Doctoral Dissertation]. University of Kentucky; 2013. Available from: https://uknowledge.uky.edu/pharmacy_etds/18

22. Benaboud, Nedjma Sihem. Pharmacocinétique de population des antirétroviraux chez la femme enceinte : Population pharmacokinetic of antiretrovirals in pregnant women.

Degree: Docteur es, Pharmacologie, 2012, Université Paris Descartes – Paris V

Des modifications physiologiques importantes interviennent au cours de la grossesse. Ces modifications ont un impact sur la pharmacocinétique et/ou la pharmacodynamique des traitements administrés. Chez… (more)

Subjects/Keywords: Pharmacocinétique de population; VIH; Grossesse; Passage transplacentaire; Allaitement; Population pharmacokinetics; HIV; Pregnancy; Placental transfer; Breastfeeding; 161.979 2061

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Benaboud, N. S. (2012). Pharmacocinétique de population des antirétroviraux chez la femme enceinte : Population pharmacokinetic of antiretrovirals in pregnant women. (Doctoral Dissertation). Université Paris Descartes – Paris V. Retrieved from http://www.theses.fr/2012PA05P648

Chicago Manual of Style (16th Edition):

Benaboud, Nedjma Sihem. “Pharmacocinétique de population des antirétroviraux chez la femme enceinte : Population pharmacokinetic of antiretrovirals in pregnant women.” 2012. Doctoral Dissertation, Université Paris Descartes – Paris V. Accessed August 07, 2020. http://www.theses.fr/2012PA05P648.

MLA Handbook (7th Edition):

Benaboud, Nedjma Sihem. “Pharmacocinétique de population des antirétroviraux chez la femme enceinte : Population pharmacokinetic of antiretrovirals in pregnant women.” 2012. Web. 07 Aug 2020.

Vancouver:

Benaboud NS. Pharmacocinétique de population des antirétroviraux chez la femme enceinte : Population pharmacokinetic of antiretrovirals in pregnant women. [Internet] [Doctoral dissertation]. Université Paris Descartes – Paris V; 2012. [cited 2020 Aug 07]. Available from: http://www.theses.fr/2012PA05P648.

Council of Science Editors:

Benaboud NS. Pharmacocinétique de population des antirétroviraux chez la femme enceinte : Population pharmacokinetic of antiretrovirals in pregnant women. [Doctoral Dissertation]. Université Paris Descartes – Paris V; 2012. Available from: http://www.theses.fr/2012PA05P648


University of Southern California

23. Kryshchenko (Chubatiuk), Alona. Nonparametric estimation of an unknown probability distribution using maximum likelihood and Bayesian approaches.

Degree: PhD, Applied Mathematics, 2013, University of Southern California

 Suppose we observe a random sample Y₁,...,YN, of independent but not necessarily identically distributed random variables Yᵢ,∈ ℝᵈ, for i = 1,...,N. Assume also that… (more)

Subjects/Keywords: statistics; nonparametric population analysis; applied statistics; population pharmacokinetics theory; nonparametric maximum likelihood estimation; nonparametric Bayesian estimation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kryshchenko (Chubatiuk), A. (2013). Nonparametric estimation of an unknown probability distribution using maximum likelihood and Bayesian approaches. (Doctoral Dissertation). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/309797/rec/4455

Chicago Manual of Style (16th Edition):

Kryshchenko (Chubatiuk), Alona. “Nonparametric estimation of an unknown probability distribution using maximum likelihood and Bayesian approaches.” 2013. Doctoral Dissertation, University of Southern California. Accessed August 07, 2020. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/309797/rec/4455.

MLA Handbook (7th Edition):

Kryshchenko (Chubatiuk), Alona. “Nonparametric estimation of an unknown probability distribution using maximum likelihood and Bayesian approaches.” 2013. Web. 07 Aug 2020.

Vancouver:

Kryshchenko (Chubatiuk) A. Nonparametric estimation of an unknown probability distribution using maximum likelihood and Bayesian approaches. [Internet] [Doctoral dissertation]. University of Southern California; 2013. [cited 2020 Aug 07]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/309797/rec/4455.

Council of Science Editors:

Kryshchenko (Chubatiuk) A. Nonparametric estimation of an unknown probability distribution using maximum likelihood and Bayesian approaches. [Doctoral Dissertation]. University of Southern California; 2013. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/309797/rec/4455

24. Wattanavijitkul, Thitima. Population pharmacokinetics of pyronaridine in the treatment of malaria.

Degree: PhD, Pharmacy, 2010, University of Iowa

  A novel pyronaridine-artesunate (PA) combination is being developed as a 3:1 fixed ratio oral combination against P. falciparum and P. vivax malaria. Pyronaridine (PYR)… (more)

Subjects/Keywords: Antimalarials; Pharmacokinetics; Population Pharmacokinetics; Pyramax; Pyronaridine; Pharmacy and Pharmaceutical Sciences

…http://ir.uiowa.edu/etd/622 POPULATION PHARMACOKINETICS OF PYRONARIDINE IN THE TREATMENT OF… …humans. In this thesis, the population pharmacokinetics (PPKs) of PYR is studied in… …each population. PYR pharmacokinetics in each population is best described by a… …____________________________________ Date POPULATION PHARMACOKINETICS OF PYRONARIDINE IN THE TREATMENT OF MALARIA by Thitima… …pharmacokinetics of PYR in humans. In this thesis, the population pharmacokinetics (PPKs) of… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wattanavijitkul, T. (2010). Population pharmacokinetics of pyronaridine in the treatment of malaria. (Doctoral Dissertation). University of Iowa. Retrieved from https://ir.uiowa.edu/etd/622

Chicago Manual of Style (16th Edition):

Wattanavijitkul, Thitima. “Population pharmacokinetics of pyronaridine in the treatment of malaria.” 2010. Doctoral Dissertation, University of Iowa. Accessed August 07, 2020. https://ir.uiowa.edu/etd/622.

MLA Handbook (7th Edition):

Wattanavijitkul, Thitima. “Population pharmacokinetics of pyronaridine in the treatment of malaria.” 2010. Web. 07 Aug 2020.

Vancouver:

Wattanavijitkul T. Population pharmacokinetics of pyronaridine in the treatment of malaria. [Internet] [Doctoral dissertation]. University of Iowa; 2010. [cited 2020 Aug 07]. Available from: https://ir.uiowa.edu/etd/622.

Council of Science Editors:

Wattanavijitkul T. Population pharmacokinetics of pyronaridine in the treatment of malaria. [Doctoral Dissertation]. University of Iowa; 2010. Available from: https://ir.uiowa.edu/etd/622


Universidade do Rio Grande do Sul

25. Nava, Tiago Rodrigues. Modelo de personalização de dose de bussulfano intravenoso baseado no genótipo de GSTA1 durante regime de condicionamento do transplante de células-tronco hematopoiéticas em crianças.

Degree: 2017, Universidade do Rio Grande do Sul

 O bussulfano (Bu) é um agente alquilante usado no condicionamento que precede o transplante de células-tronco hematopoiéticas (TCTH) em crianças. Sua farmacocinética (FC) apresenta uma… (more)

Subjects/Keywords: Hematopoietic stem cell transplantation; Transplante de células-tronco hematopoéticas; Bussulfano; Population pharmacokinetic model; Farmacogenética; GSTA1; Polymorphisms; Farmacocinética; Parmacogenetics; Pharmacokinetics; Busulfan; HSCT

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nava, T. R. (2017). Modelo de personalização de dose de bussulfano intravenoso baseado no genótipo de GSTA1 durante regime de condicionamento do transplante de células-tronco hematopoiéticas em crianças. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/169580

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Nava, Tiago Rodrigues. “Modelo de personalização de dose de bussulfano intravenoso baseado no genótipo de GSTA1 durante regime de condicionamento do transplante de células-tronco hematopoiéticas em crianças.” 2017. Thesis, Universidade do Rio Grande do Sul. Accessed August 07, 2020. http://hdl.handle.net/10183/169580.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Nava, Tiago Rodrigues. “Modelo de personalização de dose de bussulfano intravenoso baseado no genótipo de GSTA1 durante regime de condicionamento do transplante de células-tronco hematopoiéticas em crianças.” 2017. Web. 07 Aug 2020.

Vancouver:

Nava TR. Modelo de personalização de dose de bussulfano intravenoso baseado no genótipo de GSTA1 durante regime de condicionamento do transplante de células-tronco hematopoiéticas em crianças. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2017. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10183/169580.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Nava TR. Modelo de personalização de dose de bussulfano intravenoso baseado no genótipo de GSTA1 durante regime de condicionamento do transplante de células-tronco hematopoiéticas em crianças. [Thesis]. Universidade do Rio Grande do Sul; 2017. Available from: http://hdl.handle.net/10183/169580

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

26. Nogueira Filho, Marco Antonio Ferraz [UNESP]. Farmacocinética populacional pré-clínica e avaliação de segurança de formulação microemulsionada de anfotericina B.

Degree: 2016, Universidade Estadual Paulista

Depois de quase 50 anos de uso na terapia, a alta potência e amplo espectro de ação asseguram que a anfotericina B (AmB) continue a… (more)

Subjects/Keywords: Farmacocinética Populacional; Anfotericina B; Validação de método; UPLC; Avaliação de Segurança; Farmacometria; Population pharmacokinetics; Amphotericin B; Method validation; UPLC; Safety assessment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nogueira Filho, M. A. F. [. (2016). Farmacocinética populacional pré-clínica e avaliação de segurança de formulação microemulsionada de anfotericina B. (Thesis). Universidade Estadual Paulista. Retrieved from http://hdl.handle.net/11449/145012

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Nogueira Filho, Marco Antonio Ferraz [UNESP]. “Farmacocinética populacional pré-clínica e avaliação de segurança de formulação microemulsionada de anfotericina B.” 2016. Thesis, Universidade Estadual Paulista. Accessed August 07, 2020. http://hdl.handle.net/11449/145012.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Nogueira Filho, Marco Antonio Ferraz [UNESP]. “Farmacocinética populacional pré-clínica e avaliação de segurança de formulação microemulsionada de anfotericina B.” 2016. Web. 07 Aug 2020.

Vancouver:

Nogueira Filho MAF[. Farmacocinética populacional pré-clínica e avaliação de segurança de formulação microemulsionada de anfotericina B. [Internet] [Thesis]. Universidade Estadual Paulista; 2016. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11449/145012.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Nogueira Filho MAF[. Farmacocinética populacional pré-clínica e avaliação de segurança de formulação microemulsionada de anfotericina B. [Thesis]. Universidade Estadual Paulista; 2016. Available from: http://hdl.handle.net/11449/145012

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

27. Arun, K P. Impact of cyp2c19 genetic polymorphism on population pharmacokinetics of Sertraline and Omeprazole in south Indian patients;.

Degree: Pharmacy, 2014, JSS University

Included

Reference p. 197-208, Appendix p.176-195

Advisors/Committee Members: Elango, K.

Subjects/Keywords: cyp2c19 genetic polymorphism; Omeprazole; population pharmacokinetics; Sertraline

Page 1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Arun, K. P. (2014). Impact of cyp2c19 genetic polymorphism on population pharmacokinetics of Sertraline and Omeprazole in south Indian patients;. (Thesis). JSS University. Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/30850

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Arun, K P. “Impact of cyp2c19 genetic polymorphism on population pharmacokinetics of Sertraline and Omeprazole in south Indian patients;.” 2014. Thesis, JSS University. Accessed August 07, 2020. http://shodhganga.inflibnet.ac.in/handle/10603/30850.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Arun, K P. “Impact of cyp2c19 genetic polymorphism on population pharmacokinetics of Sertraline and Omeprazole in south Indian patients;.” 2014. Web. 07 Aug 2020.

Vancouver:

Arun KP. Impact of cyp2c19 genetic polymorphism on population pharmacokinetics of Sertraline and Omeprazole in south Indian patients;. [Internet] [Thesis]. JSS University; 2014. [cited 2020 Aug 07]. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/30850.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Arun KP. Impact of cyp2c19 genetic polymorphism on population pharmacokinetics of Sertraline and Omeprazole in south Indian patients;. [Thesis]. JSS University; 2014. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/30850

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universitat Autònoma de Barcelona

28. Estévez Gómez, Javier Alejandro. Efecto de las concentraciones de ritonavir en la farmacocinética de atazanavir: aplicación de técnicas de modelado y simulación farmacocinético poblacional.

Degree: Departament de Farmacologia, de Terapèutica i de Toxicologia, 2016, Universitat Autònoma de Barcelona

 Introduction: HIV infection has become a chronic and manageable condition mainly due to the successful introduction of triple antiretroviral therapy. Atazanavir(ATV) is a protease inhibitor,… (more)

Subjects/Keywords: Farmacocinètica poblacional; Farmacocinética poblacional; Population pharmacokinetics; Opitmización de dosis; Optimització dosis; Dose optimization; Atazanavir; Ritonavir; Ciències de la Salut; 615

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Estévez Gómez, J. A. (2016). Efecto de las concentraciones de ritonavir en la farmacocinética de atazanavir: aplicación de técnicas de modelado y simulación farmacocinético poblacional. (Thesis). Universitat Autònoma de Barcelona. Retrieved from http://hdl.handle.net/10803/399998

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Estévez Gómez, Javier Alejandro. “Efecto de las concentraciones de ritonavir en la farmacocinética de atazanavir: aplicación de técnicas de modelado y simulación farmacocinético poblacional.” 2016. Thesis, Universitat Autònoma de Barcelona. Accessed August 07, 2020. http://hdl.handle.net/10803/399998.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Estévez Gómez, Javier Alejandro. “Efecto de las concentraciones de ritonavir en la farmacocinética de atazanavir: aplicación de técnicas de modelado y simulación farmacocinético poblacional.” 2016. Web. 07 Aug 2020.

Vancouver:

Estévez Gómez JA. Efecto de las concentraciones de ritonavir en la farmacocinética de atazanavir: aplicación de técnicas de modelado y simulación farmacocinético poblacional. [Internet] [Thesis]. Universitat Autònoma de Barcelona; 2016. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10803/399998.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Estévez Gómez JA. Efecto de las concentraciones de ritonavir en la farmacocinética de atazanavir: aplicación de técnicas de modelado y simulación farmacocinético poblacional. [Thesis]. Universitat Autònoma de Barcelona; 2016. Available from: http://hdl.handle.net/10803/399998

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

29. NIU HUI LIAN. Clinical pharmacokinetics of low dose paclitaxel in Asian patients with nasopharyngeal carcinoma.

Degree: 2005, National University of Singapore

Subjects/Keywords: Paclitaxel; Nasopharyngeal carcinoma; Asian; Population; Pharmacokinetics; Chemosensitizer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

LIAN, N. H. (2005). Clinical pharmacokinetics of low dose paclitaxel in Asian patients with nasopharyngeal carcinoma. (Thesis). National University of Singapore. Retrieved from http://scholarbank.nus.edu.sg/handle/10635/16962

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

LIAN, NIU HUI. “Clinical pharmacokinetics of low dose paclitaxel in Asian patients with nasopharyngeal carcinoma.” 2005. Thesis, National University of Singapore. Accessed August 07, 2020. http://scholarbank.nus.edu.sg/handle/10635/16962.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

LIAN, NIU HUI. “Clinical pharmacokinetics of low dose paclitaxel in Asian patients with nasopharyngeal carcinoma.” 2005. Web. 07 Aug 2020.

Vancouver:

LIAN NH. Clinical pharmacokinetics of low dose paclitaxel in Asian patients with nasopharyngeal carcinoma. [Internet] [Thesis]. National University of Singapore; 2005. [cited 2020 Aug 07]. Available from: http://scholarbank.nus.edu.sg/handle/10635/16962.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

LIAN NH. Clinical pharmacokinetics of low dose paclitaxel in Asian patients with nasopharyngeal carcinoma. [Thesis]. National University of Singapore; 2005. Available from: http://scholarbank.nus.edu.sg/handle/10635/16962

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

30. SAM WAI JOHNN. Clinical pharmacokinetics of tacrolimus in Asian liver transplant patients.

Degree: 2004, National University of Singapore

Subjects/Keywords: Population pharmacokinetics; tacrolimus; asian; liver transplant; nonmem; FK506

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

JOHNN, S. W. (2004). Clinical pharmacokinetics of tacrolimus in Asian liver transplant patients. (Thesis). National University of Singapore. Retrieved from http://scholarbank.nus.edu.sg/handle/10635/27691

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

JOHNN, SAM WAI. “Clinical pharmacokinetics of tacrolimus in Asian liver transplant patients.” 2004. Thesis, National University of Singapore. Accessed August 07, 2020. http://scholarbank.nus.edu.sg/handle/10635/27691.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

JOHNN, SAM WAI. “Clinical pharmacokinetics of tacrolimus in Asian liver transplant patients.” 2004. Web. 07 Aug 2020.

Vancouver:

JOHNN SW. Clinical pharmacokinetics of tacrolimus in Asian liver transplant patients. [Internet] [Thesis]. National University of Singapore; 2004. [cited 2020 Aug 07]. Available from: http://scholarbank.nus.edu.sg/handle/10635/27691.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

JOHNN SW. Clinical pharmacokinetics of tacrolimus in Asian liver transplant patients. [Thesis]. National University of Singapore; 2004. Available from: http://scholarbank.nus.edu.sg/handle/10635/27691

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3]

.